Evaluation of sedative R51703 in cattle: effects on cardiorespiratory functions and rumen contraction rate

R51703, a substance with 5-hydroxytryptamine type 2 receptor antagonist properties, was studied to assess its potential as a sedative in cattle. Six cattle in the study group were given R51703 intramuscularly at a dose rate of 0.15 mg/kg. Sedation became obvious between 10 and 15 minutes postinjection in five of these animals and lasted for approximately 120 minutes. No significant changes (P less than or equal to 0.05) were observed in respiratory rate, arterial blood gas, acid-base values or systemic arterial blood pressure. Heart rate was significantly elevated at 40, 60, 90 and 120 minutes posttreatment, but dysrhythmias were not detected. Rumen motility, as judged by the contraction rate, was decreased but not to significant levels. All animals ate normally at the end of the study period. The results indicated that R51703 may have a role in the management of domestic cattle and that further work is indicated to assess its potential in this area.